Table 2. Postoperative outcomes in the study groups.
| ALT | AST | Total | |||||
| Low | Middle | High | Low | Middle | High | ||
| N | 1528 | 3512 | 1224 | 1384 | 3687 | 1193 | 6264 |
| 90-day death | 77 (5.0) | 80 (2.3) | 26 (2.1) | 46 (3.3) | 85 (2.3) | 52 (4.4) | 183 (2.9) |
| In-hospital death | 73 (4.8) | 80 (2.3) | 26 (2.1) | 42 (3.0) | 85 (2.3) | 52 (4.4) | 179 (2.9) |
| Prolonged hospital length of stay | 399 (26.1) | 714 (20.3) | 250 (20.4) | 279 (20.2) | 754 (20.5) | 330 (27.7) | 1363 (21.8) |
| Major adverse cardiovascular events | 80 (5.2) | 148 (4.2) | 52 (4.2) | 52 (3.8) | 143 (3.9) | 85 (7.1) | 280 (4.5) |
| Stroke | 49 (3.2) | 72 (2.1) | 25 (2.0) | 41 (3.0) | 73 (2.0) | 32 (2.7) | 146 (2.3) |
| Pulmonary complications | 202 (13.2) | 316 (9.0) | 97 (7.9) | 139 (10.0) | 339 (9.2) | 137 (11.5) | 615 (9.8) |
| Acute kidney injury | 181 (11.8) | 288 (8.2) | 80 (6.5) | 128 (9.2) | 297 (8.1) | 124 (10.4) | 549 (8.8) |
| Gastrointestinal complications | 20 (1.3) | 32 (0.9) | 12 (1.0) | 13 (0.9) | 40 (1.1) | 11 (0.9) | 64 (1.0) |
Data are expressed as the number of patients (%).
ALT: alanine aminotransferase; AST: aspartate aminotransferase.